Skip to content
Alzheimer’s Disease
-
Mayo Clinic develops breakthrough tool to predict Alzheimer’s risk years before symptoms appear
The study revealed that women face a higher lifetime risk than men of developing dementia and mild cognitive impairment (MCI), a transitional stage between healthy aging and dementia.
-
Siemens Healthineers to co-lead major EU Initiative advancing Alzheimer’s disease diagnosis and treatment
The ACCESS-AD project launches in January 2026 with an ambitious goal to establish a collaborative, patient-centered approach to Alzheimer’s care throughout Europe.